BERLIN, Germany, March 29, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Oliver Schacht, PhD, CFO, will present an update on the company at the Lehman Brothers 8th Annual Global Healthcare Conference. The presentation is scheduled to occur on March 31, 2005 at 2 p.m. EST at the Loews Hotel, Miami Beach, Florida, USA.
The presentation will be webcast live at http://customer.talkpoint.com/LEHM002/033005a_cs/speaker.asp?entity=Epigenomics
The webcast replay of the presentation will be archived in the investor relations events section of Epigenomics' website http://www.epigenomics.com/en/investor_relations/IR_Events/.
About Epigenomics
Epigenomics is a molecular diagnostics company with a focus on the development of novel products for cancer. By detecting and interpreting DNA methylation patterns, Epigenomics' tests can potentially diagnose disease at an early stage and help guide physicians to select an appropriate therapy. Epigenomics collaborates with Roche Diagnostics on the development of several diagnostic products in cancer. The company has its headquarters in Berlin, Germany, and a wholly owned subsidiary in Seattle, USA. For more information, please visit our website at www.epigenomics.com.
Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Epigenomics AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Epigenomics AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
-0-
CONTACT:
Epigenomics AG Halsin Partners
Hong Thieu (VP, Corporate Affairs) Mike Sinclair
+44 (0) 870 747 0880
Leila Sad (Corporate Communications) Heike Heinrichs
+49 (0) 30 24345-369 +49 (0) 89 25 55 06 50